Shandong Weigao Group Medical Polymer Company Stock Forecast for 2023 - 2025 - 2030

Updated on 05/01/2024

Stock Rating
16
Price Target
HK$7.12
Consensus
Outperform
Upside
33.33%
Analysts
2
Stock Rating
16
Upside
33.33%
Analysts
2
Price Target
HK$7.12

Shandong Weigao Group Medical Polymer Company Stock Forecast and Price Target

Year-long price target forecasts from two prominent analysts have recently been released for Shandong Weigao Group Medical Polymer Company, with an average price target of HK$7.12. This potential gain of 33.33 percent from the previous closing price in April, 2024 is calculated on a high forecast of HK$8.02 and a low estimate of HK$5.91. Even if you are not interested in 1066 stock, you should be aware of its competitors and their current standings.

HK$7.12

33.33% Upside

Outperform
Outperform

Shandong Weigao Group Medical Polymer Company Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Shandong Weigao Group Medical Polymer Company's Price has decreased from HK$7.68 to HK$0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach HK$11.10 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
HK$11.10
2025 Fair Value Forecast
HK$12.12
2026 Fair Value Forecast
HK$9.90
2027 Fair Value Forecast
HK$7.06
2028 Fair Value Forecast
HK$8.34
2029 Fair Value Forecast
HK$9.65
2030 Fair Value Forecast
HK$10.01
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A005930 Stock Forecast Samsung Electronics Outperform 10
₩77.50k Buy/Sell ₩92.49k 29.03%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$144.59 Buy/Sell $174.55 17.57%
AMGN Stock Forecast Amgen Outperform 4
$273.94 Buy/Sell $303.65 16.63%
ISRG Stock Forecast Intuitive Surgical Outperform 13
$370.62 Buy/Sell $408.45 16.02%
SYK Stock Forecast Stryker Corp Outperform 10
$336.50 Buy/Sell $353.16 9.51%

Shandong Weigao Group Medical Polymer Company Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Shandong Weigao Group Medical Polymer Company's Revenue has grown, rising from HK$11.35B to HK$13.62B – a growth of 20.04%. In the next year, analysts believe that Revenue will reach HK$15.76B – an increase of 15.70%. For the next seven years, the forecast is for Revenue to grow by 17.90%.

2024 Rev Forecast
HK$15.76B
2025 Rev Forecast
HK$17.49B
2026 Rev Forecast
HK$15.92B
2027 Rev Forecast
HK$15.20B
2028 Rev Forecast
HK$15.44B
2029 Rev Forecast
HK$16.11B
2030 Rev Forecast
HK$16.06B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SAN Stock Forecast Sanofi Outperform 16
93.08€ Buy/Sell 102.80€ 17.10%
BSX Stock Forecast Boston Scientific Buy 11
$71.87 Buy/Sell $70.14 14.09%
MDT Stock Forecast Medtronic Outperform 11
$80.24 Buy/Sell $92.47 19.02%

Shandong Weigao Group Medical Polymer Company Dividend per Share Forecast for 2023 - 2025 - 2030

Shandong Weigao Group Medical Polymer Company's Dividend per Share has grown In the last two years, rising from HK$0.13 to HK$0.17 – a growth of 30.77%. In the following year, the 7 analysts surveyed believe that Shandong Weigao Group Medical Polymer Company's Dividend per Share will decrease by 17.65%, reaching HK$0.14. For the next seven years, experts predict that Shandong Weigao Group Medical Polymer Company's Dividend per Share will grow at a rate of 0.88%.

2024 DPS Forecast
HK$0.14
2025 DPS Forecast
HK$0.17
2026 DPS Forecast
HK$0.18
2027 DPS Forecast
HK$0.18
2028 DPS Forecast
HK$0.17
2029 DPS Forecast
HK$0.17
2030 DPS Forecast
HK$0.17
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ZBH Stock Forecast Zimmer Biomet Holdings Hold 15
$120.28 Buy/Sell $132.52 13.07%
4543 Stock Forecast Terumo Outperform 18
¥5.63k Buy/Sell ¥4.97k -9.46%
BAX Stock Forecast Baxter International Inc Outperform 17
$40.37 Buy/Sell $44.86 11.47%

Shandong Weigao Group Medical Polymer Company Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
HK$2.23B
2025 FCF Forecast
HK$2.65B
2026 FCF Forecast
HK$2.23B
2027 FCF Forecast
HK$2.39B
2028 FCF Forecast
HK$2.36B
2029 FCF Forecast
HK$2.46B
2030 FCF Forecast
HK$2.38B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A028260 Stock Forecast Samsung C&T Outperform 18
₩150.10k Buy/Sell ₩157.27k 21.59%
7733 Stock Forecast Olympus Outperform 18
¥2.20k Buy/Sell ¥2.30k 9.07%
FME Stock Forecast Fresenius Medical Care AG & Co... Hold 18
39.60€ Buy/Sell 41.13€ -2.78%

Shandong Weigao Group Medical Polymer Company EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Shandong Weigao Group Medical Polymer Company's EBITDA has grown by 24.58%, rising from HK$3.00B to HK$3.74B. For the next year, analysts predict that EBITDA will reach HK$4.24B – an increase of 13.36%. Over the next seven years, experts believe that Shandong Weigao Group Medical Polymer Company's EBITDA will grow at a rate of 10.80%.

2024 EBITDA Forecast
HK$4.24B
2025 EBITDA Forecast
HK$4.62B
2026 EBITDA Forecast
HK$3.96B
2027 EBITDA Forecast
HK$3.92B
2028 EBITDA Forecast
HK$4.04B
2029 EBITDA Forecast
HK$4.24B
2030 EBITDA Forecast
HK$4.15B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SN. Stock Forecast Smith & Nephew Outperform 18
£9.79 Buy/Sell £16.09 67.62%
TFX Stock Forecast Teleflex Inc Hold 13
$208.75 Buy/Sell $263.46 26.95%
PEN Stock Forecast Penumbra Outperform 9
$196.47 Buy/Sell $258.62 46.10%

Shandong Weigao Group Medical Polymer Company EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Shandong Weigao Group Medical Polymer Company's EBIT has grown, moving from HK$2.33B to HK$2.98B – an increase of 27.55%. In the next year, analysts predict that EBIT will jump to HK$3.52B – up 18.14% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 12.92%.

2024 EBIT Forecast
HK$3.52B
2025 EBIT Forecast
HK$3.90B
2026 EBIT Forecast
HK$3.11B
2027 EBIT Forecast
HK$3.11B
2028 EBIT Forecast
HK$3.27B
2029 EBIT Forecast
HK$3.50B
2030 EBIT Forecast
HK$3.36B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
3402 Stock Forecast Toray Industries Outperform 18
¥693.90 Buy/Sell ¥891.82 34.03%
NARI Stock Forecast Inari Medical Outperform 14
$37.34 Buy/Sell $82.67 87.47%
853 Stock Forecast MicroPort Scientific Outperform 6
HK$6.29 Buy/Sell HK$2.15 -80.76%

Shandong Weigao Group Medical Polymer Company EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Shandong Weigao Group Medical Polymer Company's EPS has decreased from HK$0.45 to HK$0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach HK$0.65 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
HK$0.65
2025 EPS Forecast
HK$0.71
2026 EPS Forecast
HK$0.58
2027 EPS Forecast
HK$0.41
2028 EPS Forecast
HK$0.49
2029 EPS Forecast
HK$0.57
2030 EPS Forecast
HK$0.59
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
8086 Stock Forecast Nipro Hold 11
¥1.19k Buy/Sell ¥0.00 -7.64%
1858 Stock Forecast Beijing Chunlizhengda Medical ... Buy 18
HK$11.60 Buy/Sell HK$20.73 83.36%
1789 Stock Forecast AK Medical Holdings Buy 18
HK$5.88 Buy/Sell HK$8.31 31.29%